Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Lugli

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Oncoimmunology|May 4, 2016
Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcomeViktor H Koelzer, Katharina Canonica, Heather Dawson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 29, 2012
Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancerEva Karamitopoulou, Inti Zlobec, Viktor Kölzer, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 24, 2015
Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcomeViktor H Koelzer, Heather Dawson, Emilia Andersson, et al.
Human Pathology|September 10, 2015
Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancersViktor Hendrik Koelzer, Bettina Huber, Valentina Mele, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2021
Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancerInti Zlobec, Melanie Bächli, Francesca Galuppini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 casesAlexandar Tzankov, Annette Zimpfer, Ann-Christine Pehrs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 10, 2006
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancerAlessandro Lugli, Inti Zlobec, Ursula Günthert, et al.
Virchows Archiv : an International Journal of Pathology|November 15, 2018
Implementation of modern tools in autopsy practice-the way towards contemporary postmortal diagnosticsRupert Langer, Alexandra Tröhler, Beat Schnüriger, et al.
Histopathology|October 12, 2013
The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcomeHeather Dawson, Viktor H Koelzer, Eva Karamitopoulou, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2020
Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patientsInti Zlobec, Heather E Dawson, Annika Blank, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Oncoimmunology|May 4, 2016
Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcomeViktor H Koelzer, Katharina Canonica, Heather Dawson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 29, 2012
Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancerEva Karamitopoulou, Inti Zlobec, Viktor Kölzer, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 24, 2015
Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcomeViktor H Koelzer, Heather Dawson, Emilia Andersson, et al.
Human Pathology|September 10, 2015
Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancersViktor Hendrik Koelzer, Bettina Huber, Valentina Mele, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2021
Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancerInti Zlobec, Melanie Bächli, Francesca Galuppini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 casesAlexandar Tzankov, Annette Zimpfer, Ann-Christine Pehrs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 10, 2006
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancerAlessandro Lugli, Inti Zlobec, Ursula Günthert, et al.
Virchows Archiv : an International Journal of Pathology|November 15, 2018
Implementation of modern tools in autopsy practice-the way towards contemporary postmortal diagnosticsRupert Langer, Alexandra Tröhler, Beat Schnüriger, et al.
Histopathology|October 12, 2013
The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcomeHeather Dawson, Viktor H Koelzer, Eva Karamitopoulou, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2020
Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patientsInti Zlobec, Heather E Dawson, Annika Blank, et al.
Pageof 19